Inhibrx Biosciences, Stock Price Prediction
| INBX Stock | USD 87.52 1.39 1.61% |
Momentum 74
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (2.65) | EPS Estimate Current Year (8.12) | EPS Estimate Next Year (9.32) | Wall Street Target Price 12 | EPS Estimate Current Quarter (2.60) |
Using Inhibrx Biosciences, hype-based prediction, you can estimate the value of Inhibrx Biosciences, from the perspective of Inhibrx Biosciences, response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Inhibrx Biosciences, using Inhibrx Biosciences,'s stock options and short interest. It helps to benchmark the overall future attitude of investors towards Inhibrx using crowd psychology based on the activity and movement of Inhibrx Biosciences,'s stock price.
Inhibrx Biosciences, Short Interest
An investor who is long Inhibrx Biosciences, may also wish to track short interest. As short interest increases, investors should be becoming more worried about Inhibrx Biosciences, and may potentially protect profits, hedge Inhibrx Biosciences, with its derivative instruments, or be ready for some potential downside.
200 Day MA 17.485 | Short Percent 0.0687 | Short Ratio 6.46 | Shares Short Prior Month 1.1 M | 50 Day MA 26.8695 |
Inhibrx Biosciences, Hype to Price Pattern
Investor biases related to Inhibrx Biosciences,'s public news can be used to forecast risks associated with an investment in Inhibrx. The trend in average sentiment can be used to explain how an investor holding Inhibrx can time the market purely based on public headlines and social activities around Inhibrx Biosciences,. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Inhibrx Biosciences,'s market sentiment to its price can help taders to make decisions based on the overall investors consensus about Inhibrx Biosciences,.
Inhibrx Biosciences, Implied Volatility | 0.97 |
Inhibrx Biosciences,'s implied volatility exposes the market's sentiment of Inhibrx Biosciences, stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Inhibrx Biosciences,'s implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Inhibrx Biosciences, stock will not fluctuate a lot when Inhibrx Biosciences,'s options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Inhibrx Biosciences, to buy its stock at a price that has no basis in reality. In that case, they are not buying Inhibrx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Inhibrx Biosciences, after-hype prediction price | USD 102.1 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Inhibrx contract
Based on the Rule 16, the options market is currently suggesting that Inhibrx Biosciences, will have an average daily up or down price movement of about 0.0606% per day over the life of the 2026-03-20 option contract. With Inhibrx Biosciences, trading at USD 87.52, that is roughly USD 0.0531 . If you think that the market is fully incorporating Inhibrx Biosciences,'s daily price movement you should consider acquiring Inhibrx Biosciences, options at the current volatility level of 0.97%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Inhibrx Biosciences, Basic Forecasting Models to cross-verify your projections. Inhibrx Biosciences, After-Hype Price Prediction Density Analysis
As far as predicting the price of Inhibrx Biosciences, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Inhibrx Biosciences, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Inhibrx Biosciences,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Inhibrx Biosciences, Estimiated After-Hype Price Volatility
In the context of predicting Inhibrx Biosciences,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Inhibrx Biosciences,'s historical news coverage. Inhibrx Biosciences,'s after-hype downside and upside margins for the prediction period are 78.77 and 115.62, respectively. We have considered Inhibrx Biosciences,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Inhibrx Biosciences, is not too volatile at this time. Analysis and calculation of next after-hype price of Inhibrx Biosciences, is based on 3 months time horizon.
Inhibrx Biosciences, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Inhibrx Biosciences, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inhibrx Biosciences, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Inhibrx Biosciences,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.33 | 13.63 | 14.52 | 1.20 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
87.52 | 102.10 | 16.66 |
|
Inhibrx Biosciences, Hype Timeline
Inhibrx Biosciences, is currently traded for 87.52. The entity has historical hype elasticity of 14.52, and average elasticity to hype of competition of -1.2. Inhibrx is forecasted to increase in value after the next headline, with the price projected to jump to 102.1 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 16.66%, whereas the daily expected return is currently at 2.33%. The volatility of related hype on Inhibrx Biosciences, is about 2651.75%, with the expected price after the next announcement by competition of 86.32. Inhibrx Biosciences, currently holds 8.05 M in liabilities with Debt to Equity (D/E) ratio of 4.22, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Inhibrx Biosciences, has a current ratio of 7.36, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Inhibrx Biosciences,'s use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Inhibrx Biosciences, Basic Forecasting Models to cross-verify your projections.Inhibrx Biosciences, Related Hype Analysis
Having access to credible news sources related to Inhibrx Biosciences,'s direct competition is more important than ever and may enhance your ability to predict Inhibrx Biosciences,'s future price movements. Getting to know how Inhibrx Biosciences,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Inhibrx Biosciences, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NKTR | Nektar Therapeutics | (6.26) | 10 per month | 0.00 | (0.06) | 7.00 | (7.81) | 20.50 | |
| SNDX | Syndax Pharmaceuticals | (0.63) | 11 per month | 2.39 | 0.12 | 8.88 | (4.98) | 18.09 | |
| RLAY | Relay Therapeutics | 0.28 | 7 per month | 2.93 | 0.19 | 10.02 | (5.31) | 27.25 | |
| AMLX | Amylyx Pharmaceuticals | (0.52) | 6 per month | 0.00 | (0.04) | 7.34 | (5.24) | 17.17 | |
| ELVN | Enliven Therapeutics | 0.64 | 9 per month | 0.00 | (0.05) | 6.13 | (6.94) | 22.71 | |
| ORIC | Oric Pharmaceuticals | 0.29 | 8 per month | 0.00 | (0.10) | 5.48 | (4.48) | 34.41 | |
| IMTX | Immatics NV | 0.91 | 10 per month | 3.73 | 0.14 | 10.20 | (5.82) | 30.34 | |
| ATAI | ATAI Life Sciences | (0.10) | 9 per month | 0.00 | (0.04) | 8.37 | (8.05) | 32.85 | |
| SANA | Sana Biotechnology | 0.24 | 8 per month | 5.04 | 0.08 | 13.56 | (9.19) | 43.34 | |
| CVAC | CureVac NV | 0.01 | 9 per month | 0.00 | (0.19) | 1.76 | (2.80) | 18.10 |
Inhibrx Biosciences, Additional Predictive Modules
Most predictive techniques to examine Inhibrx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Inhibrx using various technical indicators. When you analyze Inhibrx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Inhibrx Biosciences, Predictive Indicators
The successful prediction of Inhibrx Biosciences, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Inhibrx Biosciences,, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Inhibrx Biosciences, based on analysis of Inhibrx Biosciences, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Inhibrx Biosciences,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Inhibrx Biosciences,'s related companies. | 2024 | 2025 (projected) | Dividend Yield | 0.0497 | 0.0522 | Price To Sales Ratio | 1.1K | 1.2K |
Story Coverage note for Inhibrx Biosciences,
The number of cover stories for Inhibrx Biosciences, depends on current market conditions and Inhibrx Biosciences,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Inhibrx Biosciences, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Inhibrx Biosciences,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Inhibrx Biosciences, Short Properties
Inhibrx Biosciences,'s future price predictability will typically decrease when Inhibrx Biosciences,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Inhibrx Biosciences, often depends not only on the future outlook of the potential Inhibrx Biosciences,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inhibrx Biosciences,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14.5 M | |
| Cash And Short Term Investments | 152.6 M |
Additional Tools for Inhibrx Stock Analysis
When running Inhibrx Biosciences,'s price analysis, check to measure Inhibrx Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx Biosciences, is operating at the current time. Most of Inhibrx Biosciences,'s value examination focuses on studying past and present price action to predict the probability of Inhibrx Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx Biosciences,'s price. Additionally, you may evaluate how the addition of Inhibrx Biosciences, to your portfolios can decrease your overall portfolio volatility.